These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2829795)
1. Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report. Vlaspolder F; Kraaijeveld CA; van Buuren R; Harmsen M; Benaissa-Trouw BJ; Snippe H Arch Virol; 1988; 98(1-2):123-30. PubMed ID: 2829795 [TBL] [Abstract][Full Text] [Related]
2. Detection of a shared idiotope on two encephalomyocarditis virus neutralizing monoclonal antibodies by neutralization inhibition enzyme immunoassay. Kraaijeveld CA; Oosterlaken TA; Vlaspolder F; van Dijk PW; Harmsen M; Fernández IM; Benaissa-Trouw BJ; Snippe H J Virol Methods; 1993 Oct; 44(2-3):319-28. PubMed ID: 8263123 [TBL] [Abstract][Full Text] [Related]
3. Blocking by anti-idiotypic antibodies of monoclonal antibody mediated protection in mice against encephalomyocarditis virus induced diabetes and lethal disease. Vlaspolder F; Oosterlaken TA; Harmsen M; van Dijk PW; Kievit H; Kraaijeveld CA; Snippe H Arch Virol; 1990; 110(3-4):277-85. PubMed ID: 2156488 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection. Chang GH; Luo YJ; Wu XY; Si BY; Lin L; Zhu QY Virol J; 2010 May; 7():106. PubMed ID: 20500892 [TBL] [Abstract][Full Text] [Related]
5. Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity. Jia Q; Ng Q; Chin W; Meng T; Chow VTK; Wang CI; Kwang J; He F Sci Rep; 2017 Apr; 7():46402. PubMed ID: 28422137 [TBL] [Abstract][Full Text] [Related]
6. Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies. Sriram S; Topham DJ; Huang SK; Rodriguez M J Virol; 1989 Oct; 63(10):4242-8. PubMed ID: 2550666 [TBL] [Abstract][Full Text] [Related]
7. Effects of cyclosporine on encephalomyocarditis virus infection in mice. Zhang XQ; Ho M Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):72-8. PubMed ID: 2848238 [No Abstract] [Full Text] [Related]
8. Detection by a solid phase independent enzyme immunoassay of monoclonal anti-idiotypic antibodies against monoclonal antibodies neutralizing Semliki Forest virus and encephalomyocarditis virus. Harmsen M; Oosterlaken TA; Tangerman C; Snippe H; Kraaijeveld CA J Virol Methods; 1993 Jul; 43(2):137-46. PubMed ID: 8396153 [TBL] [Abstract][Full Text] [Related]
9. Role of sex and early interferon production in the susceptibility of mice to encephalomyocarditis virus. Pozzetto B; Gresser I J Gen Virol; 1985 Apr; 66 ( Pt 4)():701-9. PubMed ID: 2580047 [TBL] [Abstract][Full Text] [Related]
10. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Foo DG; Alonso S; Chow VT; Poh CL Microbes Infect; 2007 Sep; 9(11):1299-306. PubMed ID: 17890123 [TBL] [Abstract][Full Text] [Related]
11. A serologic survey of encephalomyocarditis virus infection in pigs in Italy. Gualandi GL; Cammi G; Cardeti G Microbiologica; 1989 Apr; 12(2):129-32. PubMed ID: 2546020 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon. Chany C; Cerutti I Arch Virol; 1977; 55(3):225-31. PubMed ID: 74245 [TBL] [Abstract][Full Text] [Related]
13. Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine. Lodmell DL; Ewalt LC Infect Immun; 1978 Jan; 19(1):225-30. PubMed ID: 203533 [TBL] [Abstract][Full Text] [Related]
14. Sex hormone modulation of interferon (IFN) alpha/beta and gamma production by mouse spleen cell subsets following picornavirus infection. Ishikawa R; Bigley NJ Viral Immunol; 1990; 3(3):225-36. PubMed ID: 2175195 [TBL] [Abstract][Full Text] [Related]
15. Effect of the adjuvant dimethyl dioctadecyl ammonium bromide on the humoral and cellular immune responses to encephalomyocarditis virus. Kraaijeveld CA; la Rivière G; Benaissa-Trouw BJ; Jansen J; Harmsen T; Snippe H Antiviral Res; 1983 Sep; 3(3):137-49. PubMed ID: 6316848 [TBL] [Abstract][Full Text] [Related]
16. Application of immunoassay of encephalomyocarditis virus in cell culture with enzyme-labeled virus-specific monoclonal antibodies for rapid detection of virus, neutralizing antibodies, and interferon. Vlaspolder F; Harmsen T; van Veenendaal D; Kraaijeveld CA; Snippe H J Clin Microbiol; 1988 Dec; 26(12):2593-7. PubMed ID: 2852674 [TBL] [Abstract][Full Text] [Related]
18. Identification of antigenic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus using monoclonal antibodies. Yoon JW; Ko W; Bae YS; Pak CY; Amano K; Eun HM; Kim MK J Gen Virol; 1988 May; 69 ( Pt 5)():1085-90. PubMed ID: 2836552 [TBL] [Abstract][Full Text] [Related]
19. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Wu CN; Lin YC; Fann C; Liao NS; Shih SR; Ho MS Vaccine; 2001 Dec; 20(5-6):895-904. PubMed ID: 11738755 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo. Chen J; Yan B; Chen Q; Yao Y; Wang H; Liu Q; Zhang S; Wang H; Chen Z Arch Virol; 2014 Mar; 159(3):471-83. PubMed ID: 24057757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]